Table 2

Cardiorespiratory fitness test data at baseline (T0), after the intervention (T1) and at 24-weeks follow-up period (T2).




T0T1T2T0 vs. T1T0 vs. T2


NMSDMSDMSDTime effect
PW
Group effect
PKW
Time effect
PW
Group effect
PKW
PEAK WORKLOAD
Wpeak (W)All61118.3936.5813840138.942.0.000.757.000.739
A43119.337.3129.340.1127.541.4.000.757.002.739
B1112038.7164.535.917029.7.003.772.003.727
C6103.330.11146.723.38156.732.7.066.519.057.454
VO2peak
(mL/kg/min)
All6123.86.026.26.825.36.9.001.206.101.005
A4324.55.925.47.023.96.8.299.206.356.005
B1123.56.329.16.328.16.9.003.824.021.591
C619.56.125.14.528.03.2.046.888.028.213
VENTILATORY THRESHOLD WORKLOAD
WVT (W)
6198.529.5112.030.5105.432.1.001.579.172.590
VO2VT (mL/kg/min)
6116.14.218.24.416.74.4.000.930.528.216
pVO2VT (% VO2peak)
6168.710.670.210.367.214.1.423.419.132.397
INDICES
VE/VCO2 slope
(whole test)

6128.73.828.33.729.64.0.318.079.017.872
OUES (whole test)
611.80.62.00.61.90.6.000.281.191.158
Note: QUES: oxygen uptake efficiency slope; pVO2: percentage related to VO2peak; T0: Baseline; T1: after 16-week intervention; T2: at 24-week follow up; VCO2: carbon dioxide production; VE: ventilation; VO2: oxygen uptake; VT: Ventilatory threshold; W: power output. 
Data shown as mean (M) and standard deviation (SD).
PW, according to Wilcoxon test; PKW, according to Kruskall-Wallis test.